| Juan Carlos Nieto, MD | |
|
2140 John F Kennedy Rd, Fuerste Eye Clinic, Dubuque, IA 52002-3883 | |
| (563) 582-0769 | |
| Not Available |
| Full Name | Juan Carlos Nieto |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 18 Years |
| Location | 2140 John F Kennedy Rd, Dubuque, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780770156 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 38849 (Iowa) | Primary |
| 207W00000X | Ophthalmology | 51081-20 (Wisconsin) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Finley Hospital | Dubuque, IA | Hospital |
| Guttenberg Municipal Hospital | Guttenberg, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fuerste Eye Clinic | 0941198063 | 7 |
News Archive
Study findings suggest that use of selective serotonin reuptake inhibitors during pregnancy does not pose any increased infant mortality risk.
Rutgers scientists have found a compound in coffee that may team up with caffeine to fight Parkinson's disease and Lewy body dementia - two progressive and currently incurable diseases associated with brain degeneration.
A first-of-its-kind report released today outlines a new landscape for innovation in the 21st century, placing an increased premium on addressing local needs, marshaling the creativity of individuals and smaller organizations, and forging strategic partnerships.
Dyax Corp. today announced the pricing of an underwritten public offering of 17,000,000 shares of its common stock at a price to the public of $3.25 per share. The gross proceeds from the sale of shares, after underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $51.8 million. The offering is expected to close on or about March 30, 2010, subject to customary closing conditions.
› Verified 1 days ago
| Entity Name | Fuerste Eye Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255301875 PECOS PAC ID: 0941198063 Enrollment ID: O20040309000960 |
News Archive
Study findings suggest that use of selective serotonin reuptake inhibitors during pregnancy does not pose any increased infant mortality risk.
Rutgers scientists have found a compound in coffee that may team up with caffeine to fight Parkinson's disease and Lewy body dementia - two progressive and currently incurable diseases associated with brain degeneration.
A first-of-its-kind report released today outlines a new landscape for innovation in the 21st century, placing an increased premium on addressing local needs, marshaling the creativity of individuals and smaller organizations, and forging strategic partnerships.
Dyax Corp. today announced the pricing of an underwritten public offering of 17,000,000 shares of its common stock at a price to the public of $3.25 per share. The gross proceeds from the sale of shares, after underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $51.8 million. The offering is expected to close on or about March 30, 2010, subject to customary closing conditions.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Juan Carlos Nieto, MD 2140 John F Kennedy Rd, Fuerste Eye Clinic, Dubuque, IA 52002-3883 Ph: (563) 582-0769 | Juan Carlos Nieto, MD 2140 John F Kennedy Rd, Fuerste Eye Clinic, Dubuque, IA 52002-3883 Ph: (563) 582-0769 |
News Archive
Study findings suggest that use of selective serotonin reuptake inhibitors during pregnancy does not pose any increased infant mortality risk.
Rutgers scientists have found a compound in coffee that may team up with caffeine to fight Parkinson's disease and Lewy body dementia - two progressive and currently incurable diseases associated with brain degeneration.
A first-of-its-kind report released today outlines a new landscape for innovation in the 21st century, placing an increased premium on addressing local needs, marshaling the creativity of individuals and smaller organizations, and forging strategic partnerships.
Dyax Corp. today announced the pricing of an underwritten public offering of 17,000,000 shares of its common stock at a price to the public of $3.25 per share. The gross proceeds from the sale of shares, after underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $51.8 million. The offering is expected to close on or about March 30, 2010, subject to customary closing conditions.
› Verified 1 days ago
Justin M Risma, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2140 Jfk Rd, Suite F, Dubuque, IA 52002 Phone: 563-582-0769 Fax: 563-582-5772 | |
James Edwin Brock, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1500 Associates Dr, Dubuque, IA 52002 Phone: 563-584-4415 Fax: 563-584-4195 | |
Dr. Paul Arthur Mahlberg, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 300 N Grandview Ave, Dubuque, IA 52001 Phone: 563-588-4675 Fax: 563-588-1195 | |
Frederick Hunter Fuerste, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2140 Jfk Rd, Dubuque, IA 52002 Phone: 563-582-0769 Fax: 563-582-5772 | |
Todd Eric Sleep, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1500 Associates Dr, Dubuque, IA 52002 Phone: 563-584-4415 Fax: 563-584-4256 | |
Alethea Ann Hein, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1500 Associates Dr, Dubuque, IA 52002 Phone: 563-584-4415 Fax: 563-584-4195 | |
Kent William Baumann, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1500 Associates Dr, Dubuque, IA 52002 Phone: 563-584-4415 Fax: 563-584-4195 |